Dermorphin

Description

Dermorphin — Heptapeptide, Mu-Opioid Receptor Agonist

Dermorphin is a naturally occurring heptapeptide originally isolated from South American frog skin, identified as a selective mu-opioid receptor agonist. It is supplied for in vitro laboratory research only.

Research context

Preclinical literature has examined Dermorphin’s binding affinity and selectivity at the mu-opioid receptor subtype in radioligand-binding and receptor-signaling assays. Investigators have studied its antinociceptive pathway activity and receptor internalization kinetics in vitro, and its effect on pituitary hormone release in neuroendocrine signaling models. Model systems include cultured neuronal cell lines and isolated receptor-binding preparations.

Specification

• Available sizes: 2mg · 10mg
• Form: lyophilised powder
• Purity: ≥99% (HPLC)
• Testing: independently lot-tested by Horizon Analytical · Certificate of Analysis per lot

For laboratory research use only. This material is supplied to qualified researchers and institutions for in vitro investigational use. It is not a drug, food, cosmetic or medical device. It is not intended for human or veterinary use, for diagnosis, treatment, cure or prevention of any disease, or for any use outside a controlled laboratory environment. No statement on this site has been evaluated by the Food and Drug Administration. Keep out of reach of children.

Related Research

Compound family: LL-37, NAD+, ACTH (1-39), PT-141 Bremelanotide

Browse: Cellular & Tissue Research · All Research Peptides

Reconstitution & Lab Testing: All products independently tested by Horizon Analytical. See our Reconstitution & Lab Testing FAQ. Reconstitution typically requires BAC Water.